보고서 요약(국문)

개요
글로벌 광학 게놈 매핑(OGM) 시장은 2022년 XX백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) XX%로 성장하여 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
광학 게놈 매핑(OGM)은 개별 DNA 분자의 형광 표지 패턴을 분석하여 최대 500 염기쌍(bp) 크기까지의 게놈 전체 구조 변이를 편향 없이 평가하는 이미징 기술로, 기존 세포유전학적 접근법을 훨씬 뛰어넘는 해상도를 제공합니다.

광학 게놈 매핑은 초고분자량(UHMW) DNA 분리를 용이하게 하는 특수 설계된 추출 프로토콜에 의존합니다. 이 프로토콜은 세척 단계에서 DNA를 포획하는 데 사용되는 상자성 디스크를 활용하여 기존 컬럼 기반 추출 방법에서 발생하는 전단력을 줄입니다. 그 결과 약 150킬로베이스(kb)에서 메가베이스(Mbp) 크기의 DNA 조각이 생성되는데, 이는 기존 DNA 분리 기술로 얻은 평균 조각 크기보다 약 5~10배 더 깁니다.
시장 동향: 성장 동인 및 제약 요인
광학 매핑 기술의 지속적인 발전
광학 매핑 기술의 지속적인 발전은 시장 확장에 중요한 역할을 해왔습니다. 고해상도 이미징, DNA 라벨링 및 데이터 처리 알고리즘은 광학 게놈 매핑의 정확성과 효율성을 향상시켜 게놈 조립, 구조적 변이 식별 및 유전자형 분석과 같은 다양한 응용 분야에서 활용 가능한 옵션으로 만들었습니다.
예를 들어, 2023년 1월 Bionano Genomics는 향상된 샘플 준비 안정성, DNA 라벨링 및 이미징 처리 시간 단축, 처리량 및 품질 지표 향상을 포함하여 광학 게놈 매핑 워크플로를 위한 여러 신제품 및 개선 사항을 발표했습니다. Bionano의 새로운 샘플 준비 키트, 칩 및 장비 소프트웨어는 고객 피드백을 반영하여 개발되었으며, 더 많은 양의 일상적인 게놈 분석 응용 분야에서 성능을 향상시킬 수 있습니다.

또한, 전 세계 광학 유전체 지도 작성 시장은 정부 자금 지원 및 연구 이니셔티브 증가, 유전체 연구의 발전 등 다양한 요인에 의해 성장하고 있으며, 이는 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다.
시장 동향: 제약 요인
윤리적 개인정보 보호 문제, 광학 유전체 지도 작성이 제공하는 정확한 유전 데이터는 환자의 개인정보 보호 및 동의에 대한 윤리적 고려 사항을 제기합니다. 민감한 유전 데이터를 보호하고 환자가 유전체 검사의 의미를 완전히 이해하도록 하는 것은 기술에 대한 대중의 신뢰를 높이기 위해 해결해야 할 주요 과제입니다.
또한, 규제 장벽, 기존 시스템과의 통합 및 기타 요인도 예측 기간 동안 시장 성장을 저해할 수 있습니다.
세분화 분석
전 세계 광학 유전체 지도 작성 시장은 제품 유형, 응용 분야, 최종 사용자 및 지역별로 세분화됩니다.
제품 유형 세그먼트 중 소모품 세그먼트는 광학 유전체 지도 작성 시장 점유율의 약 43.5%를 차지했습니다.
소모품 세그먼트는 제품 유형 세그먼트 중 약 43.5%를 차지하며 예측 기간 동안 시장을 주도할 것으로 예상됩니다. 광학 유전체 매핑 시장의 소모품은 다양한 필수 품목으로 구성됩니다. 미세유체 칩, 광학 칩 및 기타 특수 재료는 이 기술의 핵심을 이룹니다. 이러한 소모품은 유전자 샘플의 정확한 처리 및 분석을 용이하게 하도록 세심하게 설계되었습니다. 연구원과 기술자는 매핑 과정 전반에 걸쳐 유전 물질의 무결성을 보장하기 위해 이러한 소모품에 의존합니다.
예를 들어, 2022년 2월 Arima Genomics는 Arima-HiC+ FFPE 키트라는 두 가지 신제품을 출시했는데, 이 키트를 사용하면 과학자들은 3D 유전체 데이터에서 구조적 변이를 찾아 발견할 수 있습니다. 구조적 변이 검출과 3D 유전체 방향 데이터를 결합함으로써 연구원들은 변이가 유전자 및 세포 기능에 어떻게 영향을 미치는지 더 잘 이해할 수 있습니다. 궁극적으로 이러한 연구 결과는 과학자들이 새로운 질병 메커니즘과 치료 표적을 발견하는 데 도움이 될 것입니다.

지리적 분석
북미는 2022년 시장 점유율의 약 38.4%를 차지했습니다.
북미는 유전체 연구 및 생명공학 발전, 협력 및 인수 등의 요인으로 인해 예측 기간 동안 전체 시장 점유율의 약 38.4%를 차지할 것으로 예상됩니다. 또한 주요 생명공학 및 제약 회사의 강력한 입지, 유전체 연구에 대한 광범위한 정부 자금 지원, 그리고 탄탄한 의료 인프라가 북미 지역의 시장 점유율 유지에 기여하고 있습니다.
예를 들어, 2021년 10월 Bionano Genomics는 유전체 데이터 분석, 해석 및 보고를 위한 고급 솔루션을 제공하는 선도적인 소프트웨어 회사인 BioDiscovery를 인수한다고 발표했습니다. Bionano와 BioDiscovery 팀은 협력하여 기존 차세대 시퀀싱 및 마이크로어레이 데이터 유형과 함께 광학 유전체 매핑 데이터를 포함하는 NxClinical 버전을 개발할 예정입니다. 향후 목표에는 RNA 발현 프로파일링, 메틸화를 포함한 후성유전학, 그리고 미래에는 단백질체학까지 확장하는 것이 포함됩니다.

COVID-19 영향 분석
COVID-19 팬데믹은 광학 유전체 지도 작성 시장에 긍정적인 영향을 미쳤습니다. 팬데믹 초기, 전 세계 연구소와 연구 기관들은 COVID-19 진단, 치료 및 백신 개발에 자원을 집중해야 했습니다. 이로 인해 유전체학과 같은 COVID-19와 무관한 과학 연구가 일시적으로 중단되었습니다.

시장 세분화
제품 유형별
• 소모품
• 기기
• 소프트웨어
응용 분야별
• 구조 변이 검출
• 게놈 조립
• 미생물 균주 유형 분류
• 기타
최종 사용자별
• 생명공학 및 제약 회사
• 임상 실험실
• 학술 연구 기관
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
시장의 주요 글로벌 업체로는 Bionano Genomics, Nucleome Informatics Private Limited, Praxis Genomics, LLC, MedGenome, INRAE(프랑스 식물 게놈 자원 센터(CNRGV)) 등이 있습니다. PerkinElmer(PerkinElmer Genomics), Genohub Inc, Hofkens Lab, Cerba, Nabsys 등이 있습니다.
주요 개발 사항
 2023년 8월, Bionano Genomics는 암 유전체 컨소시엄(CGC) 2023 연례 회의에 참가하여 고형암 및 혈액암 연구에 광학 유전체 지도 작성(OGM) 기술을 활용하는 방안을 폭넓게 발표할 예정이라고 밝혔습니다. 발표에는 Bionano의 과학 플랫폼 발표 및 포스터 발표, 그리고 암 유전체학 분야의 저명한 연구자들이 참여하는 패널 토론이 포함되었습니다.

 2023년 7월, 세포 및 분자 생물학 센터(CCMB)는 인간의 다양한 유전 질환을 유발하는 유전체 이상을 정확하게 탐지할 수 있는 최첨단 차세대 유전자 검사 방법인 '광학 유전체 지도 작성(OGM)'을 출시했습니다.

 2023년 3월, 바이오나노 지노믹스(Bionano Genomics)는 OGM 기반 임상 검사 두 가지, 즉 OGM-Dx 산전 전장 유전체 구조 변이 검사와 OGM-Dx 산후 전장 유전체 구조 변이 검사를 출시했습니다.
보고서 구매 이유:

• 제품 유형, 응용 분야, 최종 사용자 및 지역별 글로벌 광학 유전체 매핑 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악하기 위함입니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴할 수 있습니다.

• 모든 세그먼트를 포함한 광학 유전체 매핑 시장 수준의 다양한 데이터 포인트가 담긴 엑셀 데이터 시트가 제공됩니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석이 담긴 PDF 보고서입니다.

• 주요 기업의 핵심 제품을 모두 포함하는 제품 매핑 정보가 엑셀 파일로 제공됩니다.

글로벌 광학 유전체 매핑 시장 보고서는 약 77개의 표, 79개의 그림, 187페이지 분량입니다.
대상 고객 (2023년 기준):
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 연구 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Optical Genome Mapping Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX % during the forecast period 2023-2030.
Optical Genome Mapping (OGM) is an imaging technology which evaluates the fluorescent labelling pattern of individual DNA molecules to perform an unbiased assessment of genome-wide structural variants down to 500 base pairs (bp) in size,6 a resolution that far exceeds conventional cytogenetic approaches.
Optical Genome Mapping relies on a specifically designed extraction protocol facilitating the isolation of ultra-high molecular weight (UHMW) DNA. This protocol utilizes a paramagnetic disk purposed with trapping DNA for wash steps thereby reducing sheering forces present in standard column-based extraction methods. The result is DNA fragments of ~150 kilobases (kb) to megabases (Mbp) in size, ~5-10x longer than the average fragment size from conventional DNA isolation techniques.
Market Dynamics: Drivers and Restraints
Increasing advancements in optical mapping technologies
Continuous advances in optical mapping technology have been significant in market expansion. High-resolution imaging, DNA labelling, and data processing algorithms have increased the accuracy and efficiency of optical genome mapping, making it a viable option for a variety of applications such as genome assembly, structural variation identification, and genotyping.
For instance, in January 2023, Bionano Genomics announced the launch of several new products and advancements for its optical genome mapping workflow, including improved sample preparation robustness, faster turnaround time for DNA labelling and imaging, and increased throughput and quality metrics. Bionano's new sample prep kits, chips, and instrument software respond to customer feedback and can increase performance in a greater volume of routine genome analysis applications.
Furthermore, the global optical genome mapping market is also driven by various other factors like Rising government funding and research initiatives, Advancements in genomic research and others which help the market to grow during the forecast period.
Market Dynamics: Restraint
Ethical privacy concerns, the precise genetic data offered by optical genome mapping raises ethical considerations about patient privacy and consent. Protecting sensitive genetic data and ensuring that patients fully understand the ramifications of genomic testing are key difficulties that must be solved in order to increase public trust and confidence in the technology.
Furthermore, Regulatory hurdles, integration with existing systems and other factors also hamper the market growth during the forecast period.
Segment Analysis
The global optical genome mapping market is segmented based on product type, application, end-user and region.
The consumables segment from the product type segment accounted for approximately 43.5% of the optical genome mapping market share
The consumables segment from the product type segment accounted for approximately 43.5% and is expected to dominate during the forecast period. Consumables in the optical genome mapping market comprise a variety of essential items. Microfluidic chips, optical chips, and other specialized materials form the backbone of the technology. These consumables are meticulously designed to facilitate the precise handling and analysis of genetic samples. Researchers and technicians rely on these consumables to ensure the integrity of the genetic material throughout the mapping process.
For instance, in February 2022, Arima Genomics launched two new product offerings named Arima-HiC+ FFPE kit in which scientists will be able to find and discover structural variants in their 3D genomic data with this tool. By combining structural variant detection with 3D genome orientation data, researchers will gain a better understanding of how variants affect gene and cellular function. Finally, these findings will benefit scientists in the discovery of novel disease mechanisms and therapeutic targets.
Geographical Analysis
North America accounted for approximately 38.4% of the market share in 2022
North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the factors like a rise in genomics research and biotechnology advancements, collaborations and acquisitions. Also including a strong presence of leading biotechnology and pharmaceutical companies, extensive government funding for genomics research, and a robust healthcare infrastructure helps the region hold the highest market share during the forecast period.
For instance, in October 2021, Bionano Genomics announced the acquisition of BioDiscovery, a leading software company with high-class solutions for the analysis, interpretation, and reporting of genomics data. The Bionano and BioDiscovery teams will collaborate to create a version of NxClinical that includes optical genome mapping data alongside existing next-generation sequencing and microarray data types. Future goals include RNA expression profiling, epigenetics including methylation, and maybe proteomics in the future.
COVID-19 Impact Analysis
The COVID-19 pandemic aided the optical genome mapping market. During the early phases of the pandemic, labs and research institutes throughout the world had to redirect their resources and focus on COVID-19 diagnoses, treatment, and vaccine development. This caused a brief halt in non-COVID-related scientific endeavours, such as genomics.
Market Segmentation
By Product Type
• Consumables
• Instruments
• Software
By Application
• Structural Variant Detection
• Genome Assembly
• Microbial Strain Typing
• Others
By End User
• Biotechnology and Pharmaceutical Companies
• Clinical Laboratories
• Academic research institutes
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Bionano Genomics, Nucleome Informatics Private Limited, Praxis Genomics, LLC, MedGenome, INRAE (French Plant Genomic Resources Center (CNRGV)), PerkinElmer (PerkinElmer Genomics), Genohub Inc, Hofkens Lab, Cerba, Nabsys and among others.
Key Developments
 In August 2023, Bionano Genomics, Inc. stated its participation at the Cancer Genomics Consortium (CGC) 2023 Annual Meeting with a broad range of content covering the utility of optical genome mapping (OGM) for solid tumour and haematological malignancy cancer research, including scientific platform and poster presentations from Bionano and a panel discussion featuring esteemed researchers from across the cancer genomics landscape.
 In July 2023, the Centre for Cellular and Molecular Biology (CCMB) launched a state-of-the-art very high-end next-generation genetic testing method ‘Optical Genome Mapping’ (OGM) with the ability to accurately detect genomic abnormalities that cause various kinds of genetic ailments in humans.
 In March 2023, Bionano Genomics launched two novel OGM-based clinical tests, OGM-Dx prenatal whole genome structural variant and OGM-Dx postnatal whole genome structural variant.
Why Purchase the Report?
• To visualize the global optical genome mapping market segmentation based on product type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analysing trends and co-development.
• Excel data sheet with numerous data points of optical genome mapping market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global optical genome mapping market report would provide approximately 77 tables, 79 figures and 187 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing advancements in optical mapping technologies
4.1.1.2. Rising government funding and research initiatives
4.1.2. Restraints
4.1.2.1. Ethical Privacy Concern
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Pipeline Analysis
5.6. Unmet Needs
5.7. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Consumables*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Instruments
7.4. Software
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Structural Variant Detection*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Genome Assembly
8.4. Microbial Strain Typing
8.5. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Biotechnology and Pharmaceutical Companies*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Clinical Laboratories
9.4. Academic research institutes
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.5.1. China
10.5.5.2. India
10.5.5.3. Japan
10.5.5.4. Australia
10.5.5.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Bionano Genomics*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Nucleome Informatics Private Limited
12.3. Praxis Genomics, LLC
12.4. MedGenome
12.5. INRAE (French Plant Genomic Resources Center (CNRGV))
12.6. PerkinElmer (PerkinElmer Genomics)
12.7. Genohub Inc.
12.8. Hofkens Lab
12.9. Cerba
12.10. Nabsys
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Bionano Genomics, 4.	Key Developments, Nucleome Informatics Private Limited, Praxis Genomics, LLC, MedGenome, INRAE (French Plant Genomic Resources Center (CNRGV)), PerkinElmer (PerkinElmer Genomics), Genohub Inc., Hofkens Lab, Cerba, Nabsys

표 목록 (Tables)

List of Tables

Table 1 Global Optical Genome Mapping Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Optical Genome Mapping Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Optical Genome Mapping Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Optical Genome Mapping Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Optical Genome Mapping Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Optical Genome Mapping Market Value, By Product Type, 2022-2031 (US$ Million)

Table 7 Global Optical Genome Mapping Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 8 Global Optical Genome Mapping Market Value, By Application, 2022-2031 (US$ Million)

Table 9 Global Optical Genome Mapping Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 10 Global Optical Genome Mapping Market Value, By End User, 2022-2031 (US$ Million)

Table 11 Global Optical Genome Mapping Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 12 Global Optical Genome Mapping Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Optical Genome Mapping Market Value, By Product Type, 2022-2031 (US$ Million)

Table 14 North America Optical Genome Mapping Market Value, By Application, 2022-2031 (US$ Million)

Table 15 North America Optical Genome Mapping Market Value, By End User, 2022-2031 (US$ Million)

Table 16 North America Optical Genome Mapping Market Value, By Country, 2022-2031 (US$ Million)

Table 17 South America Optical Genome Mapping Market Value, By Product Type, 2022-2031 (US$ Million)

Table 18 South America Optical Genome Mapping Market Value, By Application, 2022-2031 (US$ Million)

Table 19 South America Optical Genome Mapping Market Value, By End User, 2022-2031 (US$ Million)

Table 20 South America Optical Genome Mapping Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Optical Genome Mapping Market Value, By Product Type, 2022-2031 (US$ Million)

Table 22 Europe Optical Genome Mapping Market Value, By Application, 2022-2031 (US$ Million)

Table 23 Europe Optical Genome Mapping Market Value, By End User, 2022-2031 (US$ Million)

Table 24 Europe Optical Genome Mapping Market Value, By Country, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Optical Genome Mapping Market Value, By Product Type, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Optical Genome Mapping Market Value, By Application, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Optical Genome Mapping Market Value, By End User, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Optical Genome Mapping Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East & Africa Optical Genome Mapping Market Value, By Product Type, 2022-2031 (US$ Million)

Table 30 Middle East & Africa Optical Genome Mapping Market Value, By Application, 2022-2031 (US$ Million)

Table 31 Middle East & Africa Optical Genome Mapping Market Value, By End User, 2022-2031 (US$ Million)

Table 32 Bionano Genomics: Overview

Table 33 Bionano Genomics: Product Portfolio

Table 34 Bionano Genomics: Key Developments

Table 35 Nucleome Informatics Private Limited: Overview

Table 36 Nucleome Informatics Private Limited: Product Portfolio

Table 37 Nucleome Informatics Private Limited: Key Developments

Table 38 Praxis Genomics, LLC: Overview

Table 39 Praxis Genomics, LLC: Product Portfolio

Table 40 Praxis Genomics, LLC: Key Developments

Table 41 MedGenome: Overview

Table 42 MedGenome: Product Portfolio

Table 43 MedGenome: Key Developments

Table 44 INRAE (French Plant Genomic Resources Center (CNRGV)): Overview

Table 45 INRAE (French Plant Genomic Resources Center (CNRGV)): Product Portfolio

Table 46 INRAE (French Plant Genomic Resources Center (CNRGV)): Key Developments

Table 47 PerkinElmer (PerkinElmer Genomics): Overview

Table 48 PerkinElmer (PerkinElmer Genomics): Product Portfolio

Table 49 PerkinElmer (PerkinElmer Genomics): Key Developments

Table 50 Genohub Inc.: Overview

Table 51 Genohub Inc.: Product Portfolio

Table 52 Genohub Inc.: Key Developments

Table 53 Hofkens Lab: Overview

Table 54 Hofkens Lab: Product Portfolio

Table 55 Hofkens Lab: Key Developments

Table 56 Cerba: Overview

Table 57 Cerba: Product Portfolio

Table 58 Cerba: Key Developments

Table 59 Nabsys: Overview

Table 60 Nabsys: Product Portfolio

Table 61 Nabsys: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 2 Global Optical Genome Mapping Market Share, By Product Type, 2022 & 2031 (%)

Figure 3 Global Optical Genome Mapping Market Share, By Application, 2022 & 2031 (%)

Figure 4 Global Optical Genome Mapping Market Share, By End User, 2022 & 2031 (%)

Figure 5 Global Optical Genome Mapping Market Share, By Region, 2022 & 2031 (%)

Figure 6 Global Optical Genome Mapping Market Y-o-Y Growth, By Product Type, 2022-2031 (%)

Figure 7 Consumables Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 8 Instruments Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 9 Software Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 10 Global Optical Genome Mapping Market Y-o-Y Growth, By Application, 2022-2031 (%)

Figure 11 Structural Variant Detection Application in Global Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 12 Genome Assembly Application in Global Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 13 Microbial Strain Typing Application in Global Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 14 Others Application in Global Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 15 Global Optical Genome Mapping Market Y-o-Y Growth, By End User, 2022-2031 (%)

Figure 16 Biotechnology and Pharmaceutical Companies End User in Global Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 17 Clinical Laboratories End User in Global Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 18 Academic research institutes End User in Global Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 19 Others End User in Global Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 20 Global Optical Genome Mapping Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 21 North America Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 22 Asia-Pacific Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 23 Europe Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 24 South America Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 25 Middle East and Africa Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 26 North America Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 27 North America Optical Genome Mapping Market Share, By Product Type, 2022 & 2031 (%)

Figure 28 North America Optical Genome Mapping Market Share, By Application, 2022 & 2031 (%)

Figure 29 North America Optical Genome Mapping Market Share, By End User, 2022 & 2031 (%)

Figure 30 North America Optical Genome Mapping Market Share, By Country, 2022 & 2031 (%)

Figure 31 South America Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 32 South America Optical Genome Mapping Market Share, By Product Type, 2022 & 2031 (%)

Figure 33 South America Optical Genome Mapping Market Share, By Application, 2022 & 2031 (%)

Figure 34 South America Optical Genome Mapping Market Share, By End User, 2022 & 2031 (%)

Figure 35 South America Optical Genome Mapping Market Share, By Country, 2022 & 2031 (%)

Figure 36 Europe Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 37 Europe Optical Genome Mapping Market Share, By Product Type, 2022 & 2031 (%)

Figure 38 Europe Optical Genome Mapping Market Share, By Application, 2022 & 2031 (%)

Figure 39 Europe Optical Genome Mapping Market Share, By End User, 2022 & 2031 (%)

Figure 40 Europe Optical Genome Mapping Market Share, By Country, 2022 & 2031 (%)

Figure 41 Asia-Pacific Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 42 Asia-Pacific Optical Genome Mapping Market Share, By Product Type, 2022 & 2031 (%)

Figure 43 Asia-Pacific Optical Genome Mapping Market Share, By Application, 2022 & 2031 (%)

Figure 44 Asia-Pacific Optical Genome Mapping Market Share, By End User, 2022 & 2031 (%)

Figure 45 Asia-Pacific Optical Genome Mapping Market Share, By Country, 2022 & 2031 (%)

Figure 46 Middle East & Africa Optical Genome Mapping Market Value, 2022-2031 (US$ Million)

Figure 47 Middle East & Africa Optical Genome Mapping Market Share, By Product Type, 2022 & 2031 (%)

Figure 48 Middle East & Africa Optical Genome Mapping Market Share, By Application, 2022 & 2031 (%)

Figure 49 Middle East & Africa Optical Genome Mapping Market Share, By End User, 2022 & 2031 (%)

Figure 50 Bionano Genomics: Financials

Figure 51 Nucleome Informatics Private Limited: Financials

Figure 52 Praxis Genomics, LLC: Financials

Figure 53 MedGenome: Financials

Figure 54 INRAE (French Plant Genomic Resources Center (CNRGV)): Financials

Figure 55 PerkinElmer (PerkinElmer Genomics): Financials

Figure 56 Genohub Inc.: Financials

Figure 57 Hofkens Lab: Financials

Figure 58 Cerba: Financials

Figure 59 Nabsys: Financials

글로벌 광학 유전체 지도 작성 시장 – 2023-2030

Global Optical Genome Mapping Market - 2023-2030